Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.

Mela Osorio, María J

Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status. [electronic resource] - European journal of haematology Apr 2016 - 435-42 p. digital

Publication Type: Journal Article

1600-0609

10.1111/ejh.12614 doi


Adolescent
Adult
Aged
Aged, 80 and over
Anemia--etiology
Calreticulin--genetics
Child
Female
Follow-Up Studies
Gene Expression
Humans
Janus Kinase 2--genetics
Male
Middle Aged
Mutation
Platelet Aggregation Inhibitors--administration & dosage
Primary Myelofibrosis--etiology
Quinazolines--administration & dosage
Receptors, Thrombopoietin--genetics
Retrospective Studies
Thrombocythemia, Essential--drug therapy